Proto Labs (PRLB) Liabilities and Shareholders Equity (2011 - 2026)

Proto Labs has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $778.6 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $778.6 million, up 5.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 billion (up 1.64% YoY), and the FY2025 annual result was $763.4 million, up 2.68% from the prior year.
• Liabilities and Shareholders Equity came in at $778.6 million for Q1 2026 at Proto Labs, up from $763.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $934.8 million in Q1 2022 to a low of $737.4 million in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $772.4 million (2023), against an average of $793.7 million.
• Across the five-year window, Liabilities and Shareholders Equity slipped 15.4% in 2023 and grew 5.58% in 2026, its largest moves.
• Proto Labs' Liabilities and Shareholders Equity stood at $802.2 million in 2022, then retreated by 3.72% to $772.4 million in 2023, then decreased by 3.73% to $743.5 million in 2024, then climbed by 2.68% to $763.4 million in 2025, then rose by 1.98% to $778.6 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $778.6 million (Q1 2026), $763.4 million (Q4 2025), and $756.9 million (Q3 2025), per Business Quant data.